BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7814348)

  • 21. First episodes of behavioral symptoms in Alzheimer's disease patients at age 90 and over, and early-onset Alzheimer's disease: comparison with senile dementia of Alzheimer's type.
    Hori K; Oda T; Asaoka T; Yoshida M; Watanabe S; Oyamada R; Tominaga I; Inada T
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):730-5. PubMed ID: 16401251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
    Shimabukuro J; Awata S; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?
    Sultzer DL; Gray KF; Gunay I; Wheatley MV; Mahler ME
    J Am Geriatr Soc; 2001 Oct; 49(10):1294-300. PubMed ID: 11890487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children.
    Zubieta JK; Alessi NE
    J Clin Psychopharmacol; 1992 Oct; 12(5):346-51. PubMed ID: 1479052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of trazodone in the treatment of anxiety.
    Wheatley D
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):74-83. PubMed ID: 821709
    [No Abstract]   [Full Text] [Related]  

  • 29. Serotonergic treatment for aggression in a Down's syndrome adult showing signs of Alzheimer's disease.
    Gedye A
    J Ment Defic Res; 1991 Jun; 35 ( Pt 3)():247-58. PubMed ID: 1833553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antidepressant effects of trazodone and inhibition of platelet serotonin reuptake.
    Mann JJ; Friedman E; Georgotas A; Gershon S
    Commun Psychopharmacol; 1980; 4(4):293-301. PubMed ID: 7273703
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonsedating treatments for Alzheimer's patients with behavioral problems.
    Hawkins JW
    J Clin Psychiatry; 1992 Mar; 53(3):101-2. PubMed ID: 1548245
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of aggression and irritability after head injury.
    Kant R; Smith-Seemiller L; Zeiler D
    Brain Inj; 1998 Aug; 12(8):661-6. PubMed ID: 9724837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease.
    Lawlor BA; Sunderland T; Mellow AM; Molchan SE; Martinez R; Murphy DL
    Biol Psychiatry; 1991 Jul; 30(2):140-4. PubMed ID: 1912105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of serotonergic system responsivity in Alzheimer's disease.
    Lawlor BA; Mellow AM; Sunderland T; Hill JL; Murphy DL
    Psychopharmacol Bull; 1988; 24(1):127-9. PubMed ID: 3290935
    [No Abstract]   [Full Text] [Related]  

  • 35. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.
    Nyth AL; Gottfries CG
    Br J Psychiatry; 1990 Dec; 157():894-901. PubMed ID: 1705151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trazodone for Alzheimer's disease: a naturalistic follow-up study.
    López-Pousa S; Garre-Olmo J; Vilalta-Franch J; Turon-Estrada A; Pericot-Nierga I
    Arch Gerontol Geriatr; 2008; 47(2):207-15. PubMed ID: 17897735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A placebo-controlled clinical trial.
    Amin M; Hontela S; Kussin D
    Psychopharmacol Bull; 1976 Apr; 12(2):45-6. PubMed ID: 769032
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of trazodone].
    Cwynar S; Soczyńska J; Szyburski M; Wojdyslawska I
    Psychiatr Pol; 1977; 11(3):313-7. PubMed ID: 897017
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term treatment of elderly individuals with emotional disturbances: an open study with citalopram.
    Ragneskog H; Eriksson S; Karlsson I; Gottfries CG
    Int Psychogeriatr; 1996; 8(4):659-68. PubMed ID: 9147178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A standard-controlled clinical trial.
    Derkervorkian K; Ban TA; Hontela S
    Psychopharmacol Bull; 1976 Apr; 12(2):46-7. PubMed ID: 769033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.